Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.61
+0.33 (1.55%)
Nov 3, 2026, 12:25 PM EST - Market open
Privia Health Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,760 | 2,916 | 2,346 | 2,719 | 2,596 | 2,755 | |
Market Cap Growth | -7.44% | 24.31% | -13.72% | 4.75% | -5.79% | - |
Enterprise Value | 2,357 | 2,535 | 1,978 | 2,444 | 2,312 | 2,430 |
Last Close Price | 21.28 | 23.71 | 19.55 | 23.03 | 22.71 | 25.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 98.55 | 127.25 | 163.09 | 117.81 | - | - |
Forward PE | 55.90 | 91.72 | 80.52 | 93.73 | 215.10 | 130.98 |
PS Ratio | 1.18 | 1.37 | 1.35 | 1.64 | 1.91 | 2.85 |
PB Ratio | 3.44 | 3.69 | 3.43 | 4.48 | 5.00 | 6.12 |
P/TBV Ratio | 7.97 | 9.36 | 6.11 | 8.63 | 8.25 | 11.52 |
P/FCF Ratio | 21.15 | 17.85 | 21.47 | 33.66 | 55.00 | 50.54 |
P/OCF Ratio | 21.15 | 17.85 | 21.47 | 33.66 | 55.00 | 50.04 |
PEG Ratio | - | 1.63 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.00 | 1.19 | 1.14 | 1.47 | 1.70 | 2.52 |
EV/EBITDA Ratio | 41.62 | 57.43 | 81.55 | 89.91 | - | - |
EV/EBIT Ratio | 52.80 | 74.04 | 116.45 | 118.36 | - | - |
EV/FCF Ratio | 18.07 | 15.51 | 18.10 | 30.25 | 48.99 | 44.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 |
Debt / EBITDA Ratio | 0.14 | 0.20 | 0.21 | 0.28 | - | - |
Debt / FCF Ratio | 0.07 | 0.06 | 0.05 | 0.10 | 0.24 | 0.85 |
Net Debt / Equity Ratio | -0.48 | -0.59 | -0.71 | -0.63 | -0.65 | -0.61 |
Net Debt / EBITDA Ratio | -7.09 | -10.65 | -20.02 | -14.02 | 23.13 | 1.27 |
Net Debt / FCF Ratio | -3.08 | -2.88 | -4.44 | -4.72 | -7.13 | -5.03 |
Asset Turnover | 1.71 | 1.70 | 1.63 | 1.85 | 1.83 | 1.90 |
Quick Ratio | 1.56 | 1.55 | 1.80 | 1.76 | 2.03 | 2.30 |
Current Ratio | 1.62 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 |
Return on Equity (ROE) | 4.31% | 4.03% | 2.64% | 3.73% | -2.49% | -64.21% |
Return on Assets (ROA) | 2.03% | 1.71% | 0.99% | 1.44% | -1.62% | -26.77% |
Return on Invested Capital (ROIC) | 6.52% | 8.93% | 4.90% | 7.32% | -10.66% | -161.79% |
Return on Capital Employed (ROCE) | 5.30% | 4.30% | 2.50% | 3.40% | -3.60% | -43.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.01% | 0.79% | 0.61% | 0.85% | -0.33% | -6.83% |
FCF Yield | 4.73% | 5.60% | 4.66% | 2.97% | 1.82% | 1.98% |
Buyback Yield / Dilution | -2.73% | -2.61% | -0.74% | -12.64% | -7.52% | -7.30% |